An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections,
and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Human papillomavirus (HPV) types 16 and 18 cause 70% of cervical cancer cases globally.
The nonavalent HPV vaccine (9vHPV) was licensed in 2014 and protects against the next …

Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause of
cervical cancer. Moreover, HPV type 16 (and to a lesser degree HPV type 18) is linked with …

Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It
is the second most prevalent cancer among women. It can have several causes; an infection …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …